Sara A. Hurvitz, MD, on HR+, HER2- Breast Cancer
Results of the neoMONARCH Trial
Post Date:12/15/2016 10:11 AM
Return to full list >>
Sara A. Hurvitz, MD, of the UCLA Jonsson Comprehensive Cancer Center, discussed findings on the biological effects of abemaciclib in a neoadjuvant study for postmenopausal patients at #SABCS16 (Abstract S4-06).